Price Leadership for a Global Hypermarket Chain in the MENA Region: Enhancing Growth

Unveiling the next chapter of the Pharma growth storyPharmaceutical companies often face criticism for disproportionately prioritizing new drug launches in high-income countries, while simultaneously neglecting the promotion of equitable healthcare in LMICs. Yet, these regions offer immense growth potential and a chance to promote global healthcare equity while fulfilling pharma ESG target commitm